125 related articles for article (PubMed ID: 3066876)
1. What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
Brunner HR; Waeber B; Nussberger J
J Hypertens Suppl; 1988 Dec; 6(3):S1-5. PubMed ID: 3066876
[TBL] [Abstract][Full Text] [Related]
2. Kinin-related effects of angiotensin-converting enzyme inhibition.
Bönner G
Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
Waeber B; Nussberger J; Juillerat L; Brunner HR
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of ACE inhibitors versus AT1 blockers.
Vaughan D
Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
[TBL] [Abstract][Full Text] [Related]
6. Influence of angiotensin-converting enzyme inhibition on sympathetic neurotransmission: possible roles of bradykinin and prostaglandins.
Schwieler JH; Hjemdahl P
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S39-46. PubMed ID: 1282628
[TBL] [Abstract][Full Text] [Related]
7. [Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors?].
Bönner G
Z Kardiol; 1988; 77 Suppl 3():23-7. PubMed ID: 3062958
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive drugs and fibrinolytic function.
Fogari R; Zoppi A
Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
[TBL] [Abstract][Full Text] [Related]
9. The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors.
Ganten D; Mullins J; Lindpaintner K
J Hum Hypertens; 1989 Jun; 3 Suppl 1():63-70. PubMed ID: 2674443
[TBL] [Abstract][Full Text] [Related]
10. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
[TBL] [Abstract][Full Text] [Related]
11. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
13. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
Sambhi MP; Gavras H; Robertson JI; Smith WM
West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
[TBL] [Abstract][Full Text] [Related]
14. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
15. Ace-inhibitors and experimental atherosclerosis.
Ambrosioni E; Bacchelli S; Degli Esposti D; Borghi C
Clin Exp Hypertens; 1993; 15 Suppl 1():157-72. PubMed ID: 8513307
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibitor and AT1 antagonist stimulate duodenal HCO3- secretion mediated by a common pathway - involvement of PG, NO and bradykinin.
Aihara E; Kagawa S; Hayashi M; Takeuchi K
J Physiol Pharmacol; 2005 Sep; 56(3):391-406. PubMed ID: 16204762
[TBL] [Abstract][Full Text] [Related]
17. Modulation of sympathetic control by ACE inhibitors.
Dominiak P
Eur Heart J; 1993 Nov; 14 Suppl I():169-72. PubMed ID: 8293770
[TBL] [Abstract][Full Text] [Related]
18. Role of the renal nerves and angiotensin II in the renal function curve.
Golin R; Genovesi S; Castoldi G; Wijnmaalen P; Protasoni G; Zanchetti A; Stella A
Arch Ital Biol; 1999 Aug; 137(4):289-97. PubMed ID: 10443320
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
Säynävälammi P; Pörsti I
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of renin: an updated review of the development of renin inhibitors.
Li YC
Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]